Audicin Launches Neuroscience-Based Solution That Transforms Work Time Into Recovery Time, Even in Phone-Free Zones

Audicin, a Finnish neuro-wellness startup backed by the founders of the Oura ring, today announced the launch of Audicin 2.0, the latest version of its neuroscience-based audio solution designed to help individuals and organizations regulate stress in real time. Built on music psychology and neuroscience, Audicin pairs original music from award-winning composers with precisely engineered binaural beats that drive brainwave entrainment to guide the brain toward states of recovery and focus, without requiring time or attention. Available as both a mobile app and a standalone offline device for high-security or phone-restricted environments, Audicin integrates with Oura, Apple Watch, Garmin, Whoop, and other wearables to deliver real-time, music-based interventions that help the body restore balance throughout the day.

According to the World Health Organization, work-related stress costs the global economy more than $1 trillion annually. Yet most mindfulness tools require time and focus that busy professionals don’t have. Audicin’s passive approach uses psychoacoustic entrainment – subtle sound patterns that guide the nervous system toward calm and focus – to trigger recovery during work, not just at rest.

“Stress doesn’t just affect health, it creates vulnerabilities across business, healthcare, and national security,” said Laura Avonius, CEO of Audicin. “People powering critical operations need recovery that works in real time. You can’t expect a nurse on a night shift, a soldier in the field, or a journalist in a warzone to meditate for two hours a day. We built Audicin to meet them where they are, delivering recovery during the work itself.”

Rather than just tracking stress, Audicin integrates with wearables to support real-time recovery through validated psychoacoustic techniques, bridging the gap between measurement and intervention. In a study of over 200 participants, ten minutes of listening during routine tasks produced a significant increase in relaxation. The more participants enjoyed the music, the stronger the response, showing that emotional engagement amplifies recovery.

Pilot programs have shown measurable reductions in stress and clear productivity gains.  Employees of Finland’s S-Group reported a 70% improvement in wellbeing, 20% fewer sick leaves, and a fourfold increase in productivity. A separate study with healthcare workers found a 22% rise in heart-rate variability and a 68% drop in DASS (Depression, Anxiety, and Stress Scale) scores within two weeks, proving that Audicin delivers measurable recovery, not just relaxation.

“Physiological awareness is only half the equation,” said Petteri Lahtela, co-founder of Oura and early backer of Audicin. “At Oura, we learned that awareness alone doesn’t change behavior. People need effortless ways to act on their data. Audicin makes that possible, using psychoacoustic methods to guide neural activity and activate the body’s natural recovery response. It marks a new frontier in applied neuroscience.”

Audicin’s sound protocols are grounded in more than 100 peer-reviewed studies on the impact of binaural beats on sleep, pain, stress, and cognitive performance, and developed under the guidance of neuroscientists and clinicians specializing in music psychology and applied neuroscience. Its ongoing research partnership with the University of Sheffield provides the foundation to translate decades of academic insight into real-time, sound-based interventions that restore balance to the nervous system.

“For decades, auditory neuroscience has shown that sound can do far more than influence mood: it can directly affect the nervous system,” said Dr. Victoria Williamson, music psychologist and Audicin’s co-founder and Chief Scientist. “Specific rhythms and frequencies can support the body and brain to shift from a stress state back to balance. What makes this field so exciting is that recovery isn’t limited to rest; it can be guided through sound, in real time.”

Audicin’s approach is gaining traction across healthcare, finance, and national security, with expansion programs underway in the U.S. and Europe through 2026. Backed by early investors including the founders of Oura, Audicin is advancing research and strategic partnerships under the guidance of a board of neuroscientists, clinicians, and health-tech executives. In the U.S., the company is exploring applications within defense and other high-stress operational environments, including potential programs aimed at supporting Department of Defense personnel. Access a 30-day free trial of the Audicin app with code CLARITY, or join the waitlist for the offline device at audicin.com.

Media kit with pictures